RhumbLine Advisers’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.1K | Buy |
16,709
+9,336
| +127% | +$21.3K | ﹤0.01% | 3711 |
|
|
2025
Q1 | $11.4K | Buy |
7,373
+1,033
| +16% | +$1.6K | ﹤0.01% | 3813 |
|
|
2024
Q4 | $14.9K | Buy |
6,340
+233
| +4% | +$547 | ﹤0.01% | 3836 |
|
|
2024
Q3 | $22.2K | Buy |
6,107
+305
| +5% | +$1.11K | ﹤0.01% | 3805 |
|
|
2024
Q2 | $20.2K | Buy |
5,802
+3,488
| +151% | +$12.1K | ﹤0.01% | 3873 |
|
|
2024
Q1 | $14.8K | Buy |
2,314
+1,166
| +102% | +$7.44K | ﹤0.01% | 3807 |
|
|
2023
Q4 | $7.39K | Hold |
1,148
| – | – | ﹤0.01% | 3916 |
|
|
2023
Q3 | $2.67K | Sell |
1,148
-80
| -7% | -$186 | ﹤0.01% | 4079 |
|
|
2023
Q2 | $2.92K | Buy |
+1,228
| New | +$2.92K | ﹤0.01% | 4169 |
|